Retrospective, non-interventional, longitudinal, multi-cohort/parallel group study to assess the safety, tolerability, and efficacy of analgesic therapy with cannabinoids vs. non-cannabinoids in CKD patients with peripheral neuropathic pain/muscle pain depending on the degree of renal impairment (ICD10: N18.1-5) using depersonalized 6-month data from the German Pain e-Registry (CANRELIEF)

17/09/2025
17/09/2025
EU PAS number:
EUPAS1000000738
Study
Finalised
Data sources

Data source(s), other

German Pain e-Registry
Use of a Common Data Model (CDM)

CDM mapping

No
Data quality specifications

Check conformance

Unknown

Check completeness

Unknown

Check stability

Unknown

Check logical consistency

Unknown
Data characterisation

Data characterisation conducted

No